|
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
RECRUITINGSponsored by European Institute of Oncology
Actively Recruiting
SponsorEuropean Institute of Oncology
Started2022-10-03
Est. completion2024-12-31
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06343181
Summary
Qualitative observational study with the aim to explore medication adherence in a sample of patients with metastatic breast cancer. Patients with metastatic breast cancer receiving or having received oral oncologic therapy, and attending the Division of Medical Senology at the European Institute of Oncology, will be included and enrolled in this research project."
Eligibility
Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Age over 18 years old; * Diagnosis of metastatic breast cancer; * Availability of an internet connection and a PC or Tablet (for remote focus groups); * Signing of the informed consent. Exclusion Criteria: * Presence of psychiatric or neurological conditions impairing the ability to comprehend the questions in Focus Groups or to express free consent to participate in the study; * Presence of medical or oncological conditions other than metastatic breast cancer; * Refusal to sign the informed consent.
Conditions3
Breast CancerCancerMetastatic Breast Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorEuropean Institute of Oncology
Started2022-10-03
Est. completion2024-12-31
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06343181